CD274 and neoplasm: Conventional predictive strategies, which primarily rely on microsatellite instability (MSI) status, PD‐L1 expression and tumor mutational burden (TMB), often fail to capture the dynamic nature of protein interactions and adaptive signaling networks that drive immune evasion MMR‐proficient tumors [23, 24].